SECURITIES AND EXCHANGE COMMISSION
                                      
                           Washington, D.C.  20549
                                      
                                  Form 10-Q
                                      
                                      
            (X) Quarterly Report Pursuant to Section 13 or 15(d)
                 of the Securities Exchange Act of 1934 for the
                 quarterly period ended March 31, 1996.
                                      
           ( ) Transition Report Pursuant to Section 13 or 15 (d)
                 of the Securities Exchange Act of 1934
                 for the transition period from       to       .
                                                -------  ------
                                      
                           Commission File Number
                                   0-20240
                          ----------------------
                                      
                         AMERICAN WHITE CROSS, INC.
          -----------------------------------------------------
           (Exact name of registrant as specified in its charter)


          Delaware                             06-1342417
- - -------------------------------     ----------------------------------
(State or other jurisdiction of    (I.R.S. Employer Identification No.)
incorporation or organization)


                                349 Lake Road
                            Dayville, Connecticut
- - --------------------------------------------------------------------
        (Address, including zip code, of principal executive offices)

Registrant's telephone number, including area code:  (860)  774-8541
                                                   -----------------

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period
that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days  Yes  x    No

As of May 15, 1996, 6,675,891 shares of Common Stock, $.01 par value were
outstanding.

Total sequentially numbered pages in this filing:   13.


 
                                     -2-


Part  I.  Financial Information
Item 1.   Financial Statements
                                      
                 AMERICAN WHITE CROSS, INC. AND SUBSIDIARIES
                    CONDENSED CONSOLIDATED BALANCE SHEETS
                        (Dollar amounts in thousands)

                                                  March 31,  December 31,
                                                    1996          1995
                                                  ----------   -----------
                                                          
ASSETS                                           (unaudited)    (audited)
Current assets:
  Cash                                             $   525       $   848
  Accounts receivable                               12,616        10,089
  Inventory                                         30,461        28,171
  Prepaid expenses                                     888           765
  Supplies                                           1,367         1,367
  Deferred income taxes                              1,061         1,061
  Other current assets                               1,610         1,875
                                                   -------       -------
     Total current assets                           48,528        44,176
                                                   -------       -------

Property, plant and equipment                       21,839        21,827
                                                   -------       -------
Other assets:
  Goodwill                                           6,520         6,461
  Trademarks, licenses and customer list               589           616
  Organization and deferred financing costs            959         1,046
  Noncompetition agreements                            217           242
  Deferred income taxes                              4,485         4,048
                                                   -------       -------
     Total other assets                             12,770        12,413
                                                   -------       -------
     Total assets                                  $83,137       $78,416
                                                   =======       =======



 


                                     -3-
                                      

                                      
                 AMERICAN WHITE CROSS, INC. AND SUBSIDIARIES
                    CONDENSED CONSOLIDATED BALANCE SHEETS
                        (Dollar amounts in thousands)


                                                  March 31,  December 31,
                                                    1996          1995
                                                  ----------   -----------
                                                 (unaudited)    (audited)
                                                          

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
  Current portion of long-term debt and
     capital lease obligations                     $24,168       $17,451
  Accounts payable                                  12,401        12,608
  Accrued wages                                        132           199
  Other accrued expenses                             1,518         1,547
                                                   -------       -------
     Total current liabilities                      38,219        31,805
                                                   -------       -------
Long-term debt and capital lease obligations,
  less current portion                              18,645        19,577
                                                   -------       -------
Stockholders' equity:
  Preferred stock                                        -             -
  Common stock                                          67            67
  Additional paid-in capital                        33,990        33,990
  Accumulated deficit                              (7,784)       (7,023)
                                                   -------       -------
     Total stockholders' equity                     26,273        27,034
                                                   -------       -------
     Total liabilities and stockholders'
       equity                                      $83,137       $78,416
                                                   =======       =======

The accompanying notes are an integral part of these condensed consolidated
financial statements.


 

                                -4-


                 AMERICAN WHITE CROSS, INC. AND SUBSIDIARIES
               CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                   (In thousands, except per share amounts)


                                                    Fiscal Quarter Ended
                                                    ---------------------
                                                    March 31,    April 2,
                                                      1996         1995
                                                    --------     --------
                                                          (unaudited)
                                                           
Sales                                                $22,559     $21,371

Cost of sales                                         18,180      18,323
- - -------                                              -------
Gross profit                                           4,379       3,048
                                                     -------     -------
Operating expenses:
  Selling                                              3,246       2,934
  General and administrative                           1,142         999
                                                     -------     -------
                                                       4,388       3,933
                                                     -------     -------
Loss from operations                                     (9)       (885)

Interest expense                                     (1,191)       (716)
Other income                                               2           2
                                                     -------     -------

Loss before benefit from income taxes                (1,198)     (1,599)

Benefit from income taxes (Note 3)                       437         574
                                                     -------     -------
Net loss                                            $  (761)    $(1,025)
                                                     =======      =======
Net loss per share                                  $  (.11)     $  (.15)
                                                     =======      =======
Weighted average shares outstanding                    6,676       6,676
                                                     =======      =======

The accompanying notes are an integral part of these condensed consolidated
financial statements.


 

                                   -5-

                 AMERICAN WHITE CROSS, INC. AND SUBSIDIARIES
               CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                (In thousands)

                                                    Fiscal Quarter Ended
                                                    ---------------------
                                                    March 31,    April 2,
                                                      1996         1995
                                                    ---------    --------
                                                         (unaudited)
                                                          
CASH FLOWS FROM OPERATING ACTIVITIES:
 Net loss                                           $(761)      $(1,025)
 Adjustments to reconcile net loss to
  net cash used in operating activities:
   Depreciation and amortization                       823           822
   Benefit from deferred income taxes                (437)         (574)
   Accretion of subordinated notes payable              65             -
   Changes in operating assets and liabilities:
     Accounts receivable                           (2,527)         (766)
     Inventory                                     (2,290)       (2,571)
     Prepaid expenses, supplies and other
        current assets                                 142            29
     Accounts payable and accrued expenses           (304)         2,203
                                                   -------       -------
       Net cash used in operating activities       (5,289)       (1,882)
                                                   -------       -------
CASH FLOWS FROM INVESTING ACTIVITIES:
 Purchases of property, plant and equipment          (641)         (372)
 Reimbursement of plant and equipment costs              -           758
 Increase in other assets                            (102)             -
                                                   -------       -------
       Net cash (used in) provided by
        investing activities                         (743)           386
                                                   -------       -------



 

                                   -6-


                 AMERICAN WHITE CROSS, INC. AND SUBSIDIARIES
               CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                 (Continued)
                               (In thousands)


                                                    Fiscal Quarter Ended
                                                    ---------------------
                                                    March 31,    April 2,
                                                      1996         1995
                                                    ---------    --------
                                                         (unaudited)

                                                           
CASH FLOWS FROM FINANCING ACTIVITIES:
 Borrowings on revolving credit loan, net           $6,717        $2,142
 Repayments of long-term debt                        (994)         (955)
 Deferred financing costs                             (14)           (3)
                                                    ------        ------
       Net cash provided by financing
        activities                                   5,709         1,184

       Net decrease in cash                          (323)         (312)

CASH, beginning of period                              848           898
                                                    ------        ------
CASH, end of period                                 $  525        $  586
                                                    ======        ======
Supplemental Disclosures:
 Cash paid during the fiscal quarter-
  Interest                                          $1,131         $ 828
  Income taxes                                          18            46
 Non-cash transactions-
  Capital lease obligations                              -           463
                                      
                                      
                                      
The accompanying notes are an integral part of these condensed consolidated
financial statements.


 



                                     -7-
                                      
                 AMERICAN WHITE CROSS, INC. AND SUBSIDIARIES
            NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               March 31, 1996
                                 (UNAUDITED)


1.ORGANIZATION

  American White Cross, Inc. (the Company) manufactures and markets a wide
  variety of health and personal care products.  The Company's business was
  founded in 1925, became a division of National Patent Development
  Corporation (NPDC) in 1972 (the Division) and was reorganized in April
  1991 (the Partnership Reorganization) as National Patent Medical
  Partnership, L.P. (the Partnership).  Pursuant to the Partnership
  Reorganization, the general partner acquired a 51% interest in the
  Partnership and the limited partner acquired the remaining 49% interest
  in the Partnership.

  In November 1992, NPM Healthcare Products, Inc., which was formed for
  such purpose, succeeded to the assets, liabilities and  business of the
  Partnership (the Corporate Reorganization).  In connection with the
  Corporate Reorganization and upon completion of the Company's November
  1992 public offering, the general partner contributed to the Company its
  interest in the Partnership in exchange for 1,326,000 shares of common
  stock of the Company.  In addition, the limited partner contributed to
  the Company its interest in the Partnership in exchange for 574,000
  shares of common stock of the Company and $4,550,000, which equals the
  net proceeds received by the Company from the sale of 700,000 shares of
  common stock.

  In May 1993, the Company acquired all of the outstanding capital stock of
  The American White Cross Laboratories, Inc. (AWCL) and its wholly owned
  subsidiary, Weaver Manufacturing Corporation.  In March 1994, AWCL was
  merged into the Company and the Company changed its name from NPM
  Healthcare Products, Inc. to American White Cross, Inc.
  
2.BASIS OF PRESENTATION

  The accompanying unaudited, condensed consolidated financial statements
  have been prepared by the Company in accordance with generally accepted
  accounting principles for interim financial information, and pursuant to
  the rules and regulations of the Securities and Exchange Commission.
  Certain information and footnote disclosures normally included in
  financial statements have been condensed or omitted pursuant to such
  rules and regulations, although management believes that the disclosures
  are adequate to make the information presented not misleading.  In the
  opinion of management, the accompanying condensed consolidated financial



 
                                     -8-

  statements contain all adjustments (consisting of only normal recurring
  accruals) necessary for a fair presentation of the results for the
  interim periods presented.

  The results for the first fiscal quarter ended March 31, 1996 are not
  necessarily indicative of the results to be expected for the full year.
  It is suggested that these condensed consolidated financial statements be
  read in conjunction with the financial statements and the notes thereto
  included in the Company's Form 10-K.

3.INCOME TAXES

  The Company accounts for income taxes in accordance with Statement of
  Financial Accounting Standards No. 109, "Accounting for Income Taxes."
  The benefit from income taxes includes federal and state income taxes on
  earnings generated in the United States, Puerto Rican income taxes on
  earnings generated in Puerto Rico and taxes due upon repatriation of
  Puerto Rican earnings and is based on the expected tax rate to be
  incurred for the full fiscal year.

  The Company has provided, as of March 31, 1996, a $770,000 valuation
  allowance relating to state net operating loss carryforwards which
  management deems will not be utilized due to the restructuring of the
  Company's operations which resulted in reduced levels of operations in
  certain states with carryforwards and due to relatively short
  carryforward periods for certain state net operating losses.  Although
  realization is not assured, management believes it is more likely than
  not that the value of the deferred tax asset, net of the valuation
  allowance, will be realized.  The amount of the deferred tax asset
  considered realizable, however, could be reduced in the near term if
  estimates of future taxable income during the carryforward period are
  reduced.

4.NET LOSS PER SHARE

  Net loss per share has been calculated using the weighted average number
  of shares outstanding.  The effect of stock options and warrants during
  each period is not dilutive and, therefore, not considered.

5.GOODWILL

  Goodwill, which represents the excess of the purchase price over the fair
  values of net assets acquired in connection with certain acquisitions, is
  amortized on a straight-line basis over an expected forty year life.  The
  Company assesses the recoverability of this intangible by determining
  whether the amortization of the goodwill balance over its remaining life can



 
                                     -9-


  be recovered through projected future results.  At this time the Company
  expects full recoverability.  Therefore, it is management's belief that no
  impairment of goodwill has occurred.

6.LONG-TERM DEBT

  As of March 31, 1996, the Company had approximately $18,955,000 outstanding
  under its revolving credit facility.  Borrowings bear interest at a rate per
  annum equal to the prime rate plus 1 3/4% and are secured by the Company's
  accounts receivable and inventories.  The credit facility contains financial
  and other covenants requiring the Company to maintain certain levels of
  working capital and tangible net worth, as defined, and prohibits the
  payment of dividends without the lender's consent.  As of March 31, 1996,
  the Company had approximately $4,460,000 available for additional borrowings
  under this credit facility.  The formula for determining the amount of
  available borrowings reverts gradually to the pre-amendment formula starting
  in June 1996.  The term of the facility expires on May 25, 1998 and provides
  for a termination fee of 1% through May 26, 1996 which is reduced to 1/2% if
  termination should occur on or prior to May 25, 1997, with no fee should
  termination occur after May 27, 1997.  In order to comply with a consensus
  issued in November 1995 set forth by the Emerging Issues Task Force in EITF
  95-22 regarding classification of certain debt instruments that include
  provisions for a lock box requirement and allow the lender certain
  subjective acceleration rights, all outstanding amounts are reflected as a
  component of current portion of long-term debt and capital lease obligations
  in the accompanying consolidated balance sheets as of March 31, 1996 and
  December 31, 1995.

  As of March 31, 1996, the Company had approximately $12,096,000
  outstanding under its term loans consisting of $9,324,000 outstanding
  under its original term loan dated September 1, 1994 and $2,772,000
  outstanding under two term loans which were effective September 1, 1995.
  These term loans are secured by all of the Company's machinery and
  equipment, other than the machinery and equipment which collateralizes
  capital lease obligations, and bear interest at a fixed rate of 9% and
  11.57%, respectively.  Payments on the three term loans are due in equal
  monthly installments of principal and interest over a five-year term.
  The term loans contain covenants similar to the Company's revolving
  credit facility, as well as a minimum debt service coverage ratio which
  is effective beginning March 31, 1996.

  On December 1, 1995, the Company entered into an agreement with certain
  investors to issue senior subordinated notes for proceeds of $9,000,000.
  The senior subordinated notes are subordinate in right of payment to the
  revolving credit facility and to the term loans (up to a maximum



 
                                    -10-


  aggregate principal amount of $44,000,000) and are guaranteed by the
  Company's subsidiaries.  The notes are due on December 1, 2003 and bear
  interest at an annual rate of 8% through December 1, 1996.  The interest
  rate increases by 2% annually until December 1, 1999 at which time the
  rate will be 16%.  Interest expense is being recorded using the effective
  yield method.  There is no penalty for early repayment.  The agreement
  also requires an annual monitoring fee of $75,000 to be paid by the
  Company.

  Warrants were also issued to the investors to purchase up to 1,334,511
  shares of the Company's common stock at an exercise price of $1 per
  share.  The estimated fair value of $2,086,000 was recorded as a
  reduction in the carrying value of the debt and is being recorded as
  additional interest expense using the effective yield method.  For the
  quarter ended March 31, 1996, $65,000 has been recorded as additional
  interest expense related to the fair value assigned to the warrants.

  The revolver, term loans and subordinated debt agreements contain
  financial and other covenants requiring the Company to maintain certain
  minimum debt service coverage ratios and certain levels of working
  capital and tangible net worth, as defined, and prohibit the payment of
  dividends without the lender's consent.  After giving effect to certain
  waivers received by the Company, the Company was in compliance with all
  covenants for the quarter ended March 31, 1996.

Item 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
         RESULTS OF OPERATIONS

  Sales for the first fiscal quarter of 1996 were $22,559,000 as compared
  to $21,371,000 for the same period in 1995.  This $1,188,000 (6%)
  increase was primarily due to new retail distribution of the Company's
  First Aid brand adhesive bandages, the impact of selling liquid
  nutritional supplement products in 1996 and higher sales of the Company's
  licensed character adhesive bandages.  These gains were partially offset
  by decreased sales of adhesive bandages produced on a contract basis for
  other distributors and timing related demand for first aid kits.

  Cost of sales in the first fiscal quarter of 1996 was $18,180,000, or
  80.6% of sales, compared to $18,323,000, or 85.7% of sales in the first
  fiscal quarter of 1995.  This decrease in cost of sales percentage is
  attributable to significant reductions in costs related to the relocation
  of certain of the Company's manufacturing processes to more modern, lower
  cost  facilities.  These savings, which primarily impacted direct and
  support labor costs, were partially offset by higher raw material cost as
  well as an increased level of inter-facility freight.



 
                                    -11-


  Selling expenses in the first fiscal quarter of 1996 of $3,246,000, or
  14.4% of sales, were higher than the $2,934,000, or 13.7% of sales in the
  same period last year.  The increase in cost relates to the establishment
  of a second distribution center, located at the Company's Houston, Texas
  plant.  This facility was established in order to increase service levels
  and decrease customer response time, as well as overall freight costs.
  The Company plans to distribute its products from both its Dayville,
  Connecticut and Houston, Texas facilities, and will discontinue use of
  its separately leased distribution facility in Connecticut effective June
  1, 1996.

  General and administrative expenses of $1,142,000, or 5.1% of sales, were
  $143,000 higher than in the prior year due to higher salary, travel,
  telephone and amortization costs partially offset by lower bad debts
  expenses and professional fees.

  Interest expense of $1,191,000 was 5.3% of sales for the first fiscal
  quarter of 1996 compared to $716,000, or 3.4% of sales in the same period
  of 1995.  This increase is related to both a higher level of debt
  outstanding as well as a higher average interest rate during the quarter.

  The Company operated at approximately a break-even level from operations
  in the first fiscal quarter of 1996 compared to a loss of $885,000 in the
  same period of 1995.  The improvement was primarily due to higher sales
  volume and manufacturing cost savings related to the restructuring of the
  Company's facilities completed in late 1995.


  LIQUIDITY AND CAPITAL RESOURCES

  At March 31, 1996, the Company had working capital of $10,309,000 and a
  current ratio of 1.3 to 1 as compared to $12,371,000 and 1.4 to 1 at
  December 31, 1995.

  During the first fiscal quarter of 1996, the Company used $5,289,000 of
  cash for operating activities principally due to a $2,527,000 increase in
  accounts receivable and a $2,290,000 increase in inventory levels in
  anticipation of the increased sales volume expected in the second and
  third fiscal quarters.

  The Company used $641,000 in cash for the purchase of new plant and
  equipment during the first fiscal quarter of 1996.

  As of March 31, 1996, the Company had approximately $4,460,000 available
  for additional borrowings under its revolving credit facility based upon
  current levels of eligible receivables and inventory.



 
                                    -12-


  In April 1996, the Company refinanced the subordinated note payable to
  National Patent Medical, Inc. in the principal amount of $1,800,000,
  originally due 50% in each of April 1996 and April 1997, for a cash
  payment of $50,000 and a new note in the amount of $1,750,000 with
  principal payments due over a 27 month period.  Amounts outstanding under
  the new note are convertible into a maximum number of 1,129,032 shares of
  the Company's common stock, with such number decreasing with each payment
  of principal.  The interest rate remains at prime plus one-half percent,
  however all such interest will be payable on the final maturity date of
  the new note in shares of the Company's common stock.

  Presently, the Company's primary cash requirements are for normal
  operating activities.  Management believes that the combination of the
  borrowing availability under the Company's revolving credit facility,
  existing working capital and funds anticipated to be generated from
  improvements in operating and financing activities will be sufficient to
  meet the Company's operating and capital needs for the foreseeable
  future.

Part II.  OTHER INFORMATION

 Item 5.  OTHER INFORMATION

  Effective January 6, 1996, Richard M. Rodnick resigned from the Company's
  Board of Directors.

  Effective March 21, 1996 Diane M. Smith was elected to the Company's
  Board of Directors.

 Item 6.  8-K

  There were no reports on Form 8-K filed by the Company during the first
  quarter of 1996.



 
                                    -13-


                                 SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                         AMERICAN WHITE CROSS, INC.


                    By:  s/ Thomas M. Rallo
                         ----------------------------------------------
                         Thomas M. Rallo
                         Senior Vice President, Finance & Administration and
                         Chief Accounting Officer

Date:  May 15, 1996